leadf
logo-loader
viewCatenae Innovation PLC

Catenae Innovation and BHA-Medical join forces to deliver an integrated COVID-19 test

Catenae Innovation's Guy Meyer (LON:CTEA) and BHA Medical's Gavyn Hough talks to Proactive London after the announcement of their joint venture to deliver an integrated COVID-19 test.

Meyer believes this partnership is strategically aligned and both counterparts complement each other's offering, with Catenae providing the technology part of this team.

Hough explains their global role and in supplying 350,000 kits to date to FTSE 100 companies. He says: 'We have the science, they have the technology and as a solution that is a match made in heaven'.

Quick facts: Catenae Innovation PLC

Price: 2.55 GBX

AIM:CTEA
Market: AIM
Market Cap: £5.64 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Catenae Innovation PLC named herein, including the promotion by the Company of Catenae Innovation PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Market report: Friday feels for FTSE and John Lewis announce £1b sprending spree

FTSE 100 opened higher despite the COVID-19 chaos helped by a US rally late on Thursday and a softer sterling. London’s leading index climbed 77 points to 5,910 in early trading. John Lewis Partnership has announced a £1bn overhaul plan to make the department store online-focused and reach...

1 week, 1 day ago

2 min read